KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Invested Capital (2017 - 2025)

Historic Return on Invested Capital for Vertex Pharmaceuticals (VRTX) over the last 14 years, with Q3 2025 value amounting to 0.19%.

  • Vertex Pharmaceuticals' Return on Invested Capital rose 1600.0% to 0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year increase of 1600.0%. This contributed to the annual value of 0.03% for FY2024, which is 1700.0% down from last year.
  • Vertex Pharmaceuticals' Return on Invested Capital amounted to 0.19% in Q3 2025, which was up 1600.0% from 0.19% recorded in Q2 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Return on Invested Capital peaked at 0.29% during Q2 2022, and registered a low of 0.15% during Q1 2025.
  • Its 5-year average for Return on Invested Capital is 0.18%, with a median of 0.21% in 2021.
  • Data for Vertex Pharmaceuticals' Return on Invested Capital shows a peak YoY increase of 1600bps (in 2025) and a maximum YoY decrease of -3400bps (in 2025) over the last 5 years.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Return on Invested Capital stood at 0.24% in 2021, then increased by 4bps to 0.25% in 2022, then decreased by -26bps to 0.18% in 2023, then crashed by -83bps to 0.03% in 2024, then surged by 515bps to 0.19% in 2025.
  • Its Return on Invested Capital stands at 0.19% for Q3 2025, versus 0.19% for Q2 2025 and 0.15% for Q1 2025.